Small Molecule CMO/CDMO Market Growth Outlook Through 2024-2033

Overview and Scope
A small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) is an entity that provides services to other companies in the pharmaceutical industry on a contract basis for the completion of projects and subsequent regulatory submission. These organizations offer a range of services, including contract development, manufacturing, and packaging of small-molecule drugs.

Sizing and Forecast
The small molecule cmo/cdmo market size has grown strongly in recent years. It will grow from $46.83 billion in 2023 to $50.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%.  The  growth in the historic period can be attributed to favorable government support, cost-effective solutions, growing complexity in drug development, industry consolidation, focus on core competencies.

The small molecule cmo/cdmo market size is expected to see strong growth in the next few years. It will grow to $68.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.  The growth in the forecast period can be attributed to rise in drug pipelines, globalization of pharmaceutical operations, demand for flexible manufacturing, regulatory compliance expertise, biopharmaceutical convergence. Major trends in the forecast period include sustainable and green manufacturing practices, increased collaboration and partnerships, personalized medicine and niche therapies, rise in virtual and virtual-to-reality companies, integration of digital technologies, rapid response manufacturing.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Segmentation & Regional Insights
The small molecule cmo/cdmo market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

North America  was the largest region in the Small Molecule CMO/CDMO market in 2023. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

Major Driver Impacting Market Growth
The rising demand for pharmaceuticals is expected to propel the growth of the small-molecule CMO/CDMO market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. Small-molecule CMO/CDMO is used in the pharmaceutical industry to outsource various services, including the development, manufacturing, and packaging of small-molecule drugs, allowing pharmaceutical companies to reduce costs, save time, and streamline processes. For instance, in May 2021, according to reports published by IQVIA Inc., a US-based pharmaceutical company, the projected total expenditure on pharmaceuticals in the US is anticipated to range between $380 to $400 billion by the year 2025, up from $359 billion in 2020, reflecting a compound annual growth rate of 3%. Therefore, the rising demand for pharmaceuticals is driving the growth of the small-molecule CMO/CDMO market.

Key Industry Players
Major companies operating in the small molecule cmo/cdmo market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc. , Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services

The small molecule cmo/cdmo market report table of contents includes:
1. Executive Summary

2. Small Molecule CMO/CDMO Market Characteristics
3. Small Molecule CMO/CDMO Market Trends And Strategies
4. Small Molecule CMO/CDMO Market – Macro Economic Scenario
5. Global Small Molecule CMO/CDMO Market Size and Growth

.

32. Global Small Molecule CMO/CDMO Market Competitive Benchmarking
33. Global Small Molecule CMO/CDMO Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Small Molecule CMO/CDMO Market
35. Small Molecule CMO/CDMO Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model